No connection

Search Results

AKAN vs HCTI

AKAN
Akanda Corp.
BEARISH
Price
$0.82
Market Cap
$1.7M
Sector
Healthcare
AI Confidence
95%
HCTI
Healthcare Triangle, Inc.
BEARISH
Price
$2.40
Market Cap
$2.8M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
AKAN
0.01
HCTI
--
Forward P/E
AKAN
--
HCTI
-0.08
P/B Ratio
AKAN
0.04
HCTI
0.14
P/S Ratio
AKAN
2.06
HCTI
0.21
EV/EBITDA
AKAN
0.55
HCTI
-1.29

Profitability

Gross Margin
AKAN
24.91%
HCTI
13.12%
Operating Margin
AKAN
-443.84%
HCTI
-74.26%
Profit Margin
AKAN
-266.31%
HCTI
-48.84%
ROE
AKAN
-60.86%
HCTI
-183.0%
ROA
AKAN
-28.69%
HCTI
-39.27%

Growth

Revenue Growth
AKAN
--
HCTI
44.6%
Earnings Growth
AKAN
--
HCTI
--

Financial Health

Debt/Equity
AKAN
0.12
HCTI
0.18
Current Ratio
AKAN
1.25
HCTI
2.03
Quick Ratio
AKAN
0.89
HCTI
1.94

Dividends

Dividend Yield
AKAN
--
HCTI
--
Payout Ratio
AKAN
0.0%
HCTI
0.0%

AI Verdict

AKAN BEARISH

AKAN exhibits severe financial distress, evidenced by a Piotroski F-Score of 3/9 (indicating weak operational health) and a lack of an Altman Z-Score, which raises red flags for potential bankruptcy risk. The company is unprofitable with negative margins across all key metrics, including a staggering -266.31% profit margin and -60.86% ROE. Despite a low Price/Book of 0.04 and a Graham Number of $281.01, the stock trades at $0.82—well below fair value—due to extreme operational failure and lack of sustainable growth. The 52-week price range shows a collapse from $46.45 to $0.81, reflecting a 100% decline over five years and confirming deep investor skepticism.

Strengths
Graham Number suggests a defensive fair value of $281.01
Low Price/Book ratio (0.04) indicates potential undervaluation on asset basis
Debt/Equity ratio of 0.12 suggests conservative capital structure
Risks
Piotroski F-Score of 3/9 signals weak financial health and operational inefficiency
Negative profit, operating, and return metrics across the board (ROE: -60.86%, ROA: -28.69%)
No revenue or earnings growth data available, suggesting stagnation or collapse
HCTI BEARISH

HCTI presents a classic value trap scenario, characterized by a stable Piotroski F-Score of 4/9 but catastrophic price action and fundamental decay. While the company shows strong top-line revenue growth of 44.6%, it is coupled with a disastrous ROE of -183% and an operating margin of -74.26%. The extreme discrepancy between the 52-week high ($7470) and current price ($2.40) indicates a total collapse in investor confidence or a massive corporate restructuring. Despite low debt and a healthy current ratio, the lack of profitability and negative earnings surprises make this a high-risk speculative asset.

Strengths
Strong YoY revenue growth of 44.60%
Low Debt/Equity ratio of 0.18
Healthy liquidity with a Current Ratio of 2.03
Risks
Catastrophic price performance (-99.9% 1Y change)
Severe negative profitability (Profit Margin -48.84%)
Extreme equity erosion (ROE -183%)

Compare Another Pair

AKAN vs HCTI: Head-to-Head Comparison

This page compares Akanda Corp. (AKAN) and Healthcare Triangle, Inc. (HCTI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile